CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Up 2,438.7% in November

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) saw a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 190,400 shares, a growth of 2,438.7% from the October 31st total of 7,500 shares. Based on an average daily volume of 241,500 shares, the short-interest ratio is presently 0.8 days.

CNBX Pharmaceuticals Price Performance

OTCMKTS CNBX opened at $0.01 on Friday. CNBX Pharmaceuticals has a 12-month low of $0.01 and a 12-month high of $0.02. The firm’s fifty day simple moving average is $0.01 and its two-hundred day simple moving average is $0.01.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.